Company Profile
Progyny Stock Price, News & Analysis
- Ticker:
- PGNY
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
31.59 USD (+1.28%)
Close
Last updated: July 27, 2026
1.97B USD
Market cap
Why the stock is moving
As of Jul 27, 2026, PGNY closed up 1.28% at $31.59. No new same-company headline was identified in the current news window.
Company overview
Business overview
Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Progyny sits in healthcare benefits and services.
Business Model Characteristics
The business depends on employer contracts, fertility-treatment utilization, and the expansion of reproductive-health benefits.
Position Within the Biotechnology Landscape
Progyny is not a biotech name; it is a benefits platform with exposure to fertility demand and healthcare utilization.
Future catalysts
Progyny's catalysts are fertility-benefit renewals, member growth, and deeper utilization across its women’s health platform. The company needs to show that its employer relationships keep turning into repeatable revenue.
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026
DGX · Source: Quest Diagnostics
- 02
- 03
Teladoc Health to Announce Second Quarter 2026 Financial Results
TDOC · Source: Teladoc
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Progyny (PGNY)?
Progyny (PGNY) most recently closed at 31.59 USD, a +1.28% move versus the previous session.
What is the market cap of Progyny (PGNY)?
Progyny currently has a market capitalization of 1.97B USD on BioPharmSignal.
What does Progyny do?
Progyny is a fertility and family-building benefits company serving employers and their members through specialized reproductive-health services.
On which exchange is PGNY stock listed?
Progyny (PGNY) is associated with NASDAQ, United States, Biopharma.
What is Progyny?
Progyny's catalysts are fertility-benefit renewals, member growth, and deeper utilization across its women’s health platform.
Which conditions is Progyny targeting with Progyny?
Progyny's catalysts are fertility-benefit renewals, member growth, and deeper utilization across its women’s health platform.
How does Progyny describe recent progress with Progyny?
Progyny's catalysts are fertility-benefit renewals, member growth, and deeper utilization across its women’s health platform.
What future catalysts are investors watching for Progyny?
Progyny's catalysts are fertility-benefit renewals, member growth, and deeper utilization across its women’s health platform. The company needs to show that its employer relationships keep turning into repeatable revenue.